The estimated burden of HIV/AIDS in Uganda, 2005-2010

被引:29
作者
Hladik, Wolfgang [1 ]
Musinguzi, Joshua [2 ]
Kirungi, Wilford [2 ]
Opio, Alex [2 ]
Stover, John [3 ]
Kaharuza, Frank [1 ]
Bunnell, Rebecca [1 ]
Kafuko, Jessica [4 ]
Mermin, Jonathan [1 ]
机构
[1] US Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Global AIDS Program, Entebbe, Uganda
[2] Minist Hlth, Kampala, Uganda
[3] Futures Inst, Glastonbury, CT USA
[4] US Agcy Int Dev, Kampala, Uganda
关键词
AIDS; antiretroviral therapy; disease burden; HIV; incidence; morbidity; mortality; prevalence; Uganda;
D O I
10.1097/QAD.0b013e3282f470be
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To estimate the burden of HIV disease in Uganda and the effect of HIV/AIDS control programmes to mitigate it. Design: Mathematical modelling and projecting using surveillance and census data. Methods: Using antenatal clinic surveillance (1986-2002) and a recent populationbased survey (2004-2005) data, we modelled the adult national HIV prevalence over time (1981 -2004), and kept prevalence constant at 6.4% for the years 2004-2010. Using Spectrum software and census data, we estimated the national burden of HIV disease and the effect of selected HIV-related prevention and treatment programmes. Results: In 2005, we estimated that there were 135 300 new HIV infections (adult HIV incidence 0.96%), 691 900 asymptomatic prevalent infections, 88 100 AIDS cases, and 76 400 AIDS deaths. An estimated 647 000 (80%) HIV-infected adults were unaware of their infection; one third of all adult deaths were HIV related. As a result of population growth, by 2008 a similar number of people will be HIV infected (1.1 million) as during the peak of the epidemic in 1994. Although antiretroviral therapy (ART) coverage is expected to rise from 67 000 (2005) to 160 000 (2010), the number of persons needing but not receiving ART will decrease only slightly from 127 600 (2005) to I 11 100 (2010). The use of single-dose in 2005 nevirapine probably averted only 4% of the estimated 20400 vertical infections. Conclusion: HIV/AIDS continues to be a leading cause of adult disease and death in Uganda. Universal ART access is probably unachievable. With the absolute burden of HIV disease approaching the historic peak in the early 1990s, more effective prevention programmes are of paramount importance. (c) 2008 Wolters Kluwer Health I Lippincott Williams & Wilkins.
引用
收藏
页码:503 / 510
页数:8
相关论文
共 28 条
[1]  
[Anonymous], GUID COND HIV SENT S
[2]   SURVEILLANCE FOR AIDS IN UGANDA [J].
BERKLEY, S ;
OKWARE, S ;
NAAMARA, W .
AIDS, 1989, 3 (02) :79-85
[3]  
Bond C, 1986, New Afr, P30
[4]  
CARSWELL JW, 1987, AIDS, V1, P192
[5]  
Elangot F, 1987, AIDS Action, P6
[6]  
GHYS PD, 2004, SEX TRANSM INFECT S1, V1, P5
[7]  
Guay LA, 1996, PEDIATRICS, V98, P438
[8]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial [J].
Jackson, JB ;
Musoke, P ;
Fleming, T ;
Guay, LA ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Owor, M ;
Ducar, C ;
Deseyve, M ;
Mwatha, A ;
Emel, L ;
Duefield, C ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Gigliotti, M ;
Bray, D ;
Mmiro, F .
LANCET, 2003, 362 (9387) :859-868
[9]   Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study [J].
Mbulaiteye, SM ;
Mahe, C ;
Whitworth, JAG ;
Ruberantwari, A ;
Nakiyingi, JS ;
Ojwiya, A ;
Kamali, A .
LANCET, 2002, 360 (9326) :41-46
[10]   Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis [J].
McNaghten, AD ;
Hanson, DL ;
Jones, JL ;
Dworkin, MS ;
Ward, JW .
AIDS, 1999, 13 (13) :1687-1695